|
 |
|
UK Enteric Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia....
|
 |
|
$2200.00 |
| |
|
|
|
France Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used
for STD testing;
|
|
|
$1950.00 |
| |
|
|
|
Italy Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: -� Examines market applications of Molecular Diagnostics,��
���Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; -� Reviews features and operating characteristics of major analyzers used
�� for STD testing;
|
|
|
$1950.00 |
| |
|
|
|
Germany Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. In addition to market share and sales forecasts, the report: - Examines market applications of Molecular Diagnostics,
Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used
for STD testing;
|
|
|
$1950.00 |
| |
|
|
|
Spain Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the Spanish STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.���� In addition to market share and sales forecasts, the report: -� Examines market applications of Molecular Diagnostics,��
���Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; -� Reviews features and operating characteristics of major analyzers used
�� for STD testing;
|
|
|
$1950.00 |
| |
|
|
|
UK Sexually-Transmitted Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.� The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.���� In addition to market share and sales forecasts, the report: -� Examines market applications of Molecular Diagnostics,��
���Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; -� Reviews features and operating characteristics of major analyzers used
�� for STD testing;
|
|
|
$1950.00 |
| |
|
|
|
France Respiratory Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs....
|
|
|
$1950.00 |
| |
|
|
|
Germany Respiratory Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs....
|
|
|
$1950.00 |
| |
|
|
|
Italy Respiratory Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs....
|
|
|
$1950.00 |
| |
|
|
|
Spain Respiratory Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals and Commercial/Private Labs....
|
|
|
$1950.00 |
| |
|
|
|
UK Respiratory Diseases: Market Outlook and Emerging Opportunities
About This Report This report presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.� The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs....
|
|
|
$1950.00 |
| |
|
|
|
Leading Infectious Disease Market Players: Insightful Profiles of Major Suppliers and Emerging Market Entrants
This report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 90 pages
|
|
|
$1850.00 |
| |
|
|
|
Infectious Disease Testing Instrumentation: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers
This report reviews major analyzers used for infectious disease testing, including their operating characteristics, features and selling prices.Contains 20 pages
|
|
|
$1850.00 |
| |
|
|
|
The US AIDS Diagnostics Market Test Volumes, Sales Forecasts, and Supplier Shares
This report presents a detailed analysis of the US AIDS diagnostics market, including test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
|
|
|
$1850.00 |
| |
|
|
|
HIV/AIDS Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--France, Germany, Italy, Japan, Spain, UK, USA--Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
This 7-country report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan for HIV-1/2/Combo, HIV Ag, Western Blot and other confirmatory assays performed in the following markets:
|
|
|
$1850.00 |
| |
|
|
|
Herpes Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--France, Germany, Italy, Japan, Spain, UK, USA--Hospitals, Commercial and Public Health Labs, POC Locations
This report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Herpes Simplex I/II and Herpes Type VI tests performed in the following market segments:
|
|
|
$1450.00 |
| |
|
|
|
France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents French test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot, and other confirmatory assays performed in the following market segments:
|
|
|
$1450.00 |
| |
|
|
|
Germany HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
This DataPack presents German test volume and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments:
|
|
|
$1450.00 |
| |
|
|
|
|